Alert detail
FDA Approval: SYNALGOS-DC (ASPIRIN) — Type 4 - New Combination
Policy ID: FDA-NDA011483Specialty: Pain ManagementAdded: 6/25/2026Effective: 1958-07-07federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.